Physiochemical properties and antitumor activities of chemically modified derivatives of antitumor glucan "grifolan LE" from Grifola frondosa - PubMed (original) (raw)
Physiochemical properties and antitumor activities of chemically modified derivatives of antitumor glucan "grifolan LE" from Grifola frondosa
Y Adachi et al. Chem Pharm Bull (Tokyo). 1989 Jul.
Abstract
Antitumor glucan, grifolan LE (GRN LE), from Grifola frondosa was chemically modified to examine the structure-function relationship of the products. Modification by periodate, borohydride and acid hydrolysis of side chains of GRN LE did not alter properties such as helical conformation and antitumor activity of GRN LE. Introduction of carboxylic acid groups into the side chains by oxidation with periodate and with sodium chlorite (GRN LE-PC), and substitution with carboxymethyl (CM) or hydroxyethyl (HE) groups abolished the gel-forming ability of GRN LE. Significant antitumor activity was observed in all of the derivtives having gel-forming ability as well as some derivatives having no such ability. These results suggested that essential factors required for antitumor activity were (1----3)-beta-D-glucosyl linkages and high molecular weight, and that accessory groups could be linked to the main chain without loss of antitumor activity in a higher ratio than that of gel-forming ability.
Similar articles
- Antitumor activity of a beta-1,3-glucan obtained from liquid cultured mycelium of Grifola frondosa.
Ohno N, Adachi Y, Suzuki I, Oikawa S, Sato K, Ohsawa M, Yadomae T. Ohno N, et al. J Pharmacobiodyn. 1986 Oct;9(10):861-4. doi: 10.1248/bpb1978.9.861. J Pharmacobiodyn. 1986. PMID: 3820062 - An unambiguous structural elucidation of a 1,3-beta-D-glucan obtained from liquid-cultured Grifola frondosa by solution NMR experiments.
Tada R, Adachi Y, Ishibashi K, Ohno N. Tada R, et al. Carbohydr Res. 2009 Feb 17;344(3):400-4. doi: 10.1016/j.carres.2008.11.005. Epub 2008 Nov 13. Carbohydr Res. 2009. PMID: 19084824 - Structure-function Relationship of antitumor beta-1,3-glucan obtained from matted mycelium of cultured Grifola frondosa.
Iino K, Ohno N, Suzuki I, Sato K, Oikawa S, Yadomae T. Iino K, et al. Chem Pharm Bull (Tokyo). 1985 Nov;33(11):4950-6. doi: 10.1248/cpb.33.4950. Chem Pharm Bull (Tokyo). 1985. PMID: 3830423 No abstract available. - Relationship between solubility of grifolan, a fungal 1,3-beta-D-glucan, and production of tumor necrosis factor by macrophages in vitro.
Ishibashi K, Miura NN, Adachi Y, Ohno N, Yadomae T. Ishibashi K, et al. Biosci Biotechnol Biochem. 2001 Sep;65(9):1993-2000. doi: 10.1271/bbb.65.1993. Biosci Biotechnol Biochem. 2001. PMID: 11676011 - Distribution of grifolan NMF-5N (I/B), a chemically modified antitumor beta-glucan in mice.
Takeyama T, Suzuki I, Ohno N, Oikawa S, Sato K, Ohsawa M, Yadomae T. Takeyama T, et al. J Pharmacobiodyn. 1988 Jun;11(6):381-5. doi: 10.1248/bpb1978.11.381. J Pharmacobiodyn. 1988. PMID: 3171879
Cited by
- Characterization of beta-glucan recognition site on C-type lectin, dectin 1.
Adachi Y, Ishii T, Ikeda Y, Hoshino A, Tamura H, Aketagawa J, Tanaka S, Ohno N. Adachi Y, et al. Infect Immun. 2004 Jul;72(7):4159-71. doi: 10.1128/IAI.72.7.4159-4171.2004. Infect Immun. 2004. PMID: 15213161 Free PMC article. - Positive modulation of a new reconstructed human gut microbiota by Maitake extract helpfully boosts the intestinal environment in vitro.
De Giani A, Perillo F, Baeri A, Finazzi M, Facciotti F, Di Gennaro P. De Giani A, et al. PLoS One. 2024 Apr 11;19(4):e0301822. doi: 10.1371/journal.pone.0301822. eCollection 2024. PLoS One. 2024. PMID: 38603764 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Miscellaneous